Home > Insider Trading > Filing (0001739614-23-000014)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1739614	Inhibrx Inc.	INBX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366074	Mark Lappe	C/O Inhibrx, Inc. 11025 North Torrey Pines Road, Suite 200 La Jolla CA 92037	Chief Executive Officer	Yes	Yes	No	No
1821266	Trust Family Lappe	C/O Inhibrx, Inc. 11025 North Torrey Pines Road, Suite 200 La Jolla CA 92037		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-02-28	60	$25.02	2,486,192	No	4	S	Indirect	By the Lappe Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By the Lappe Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	500,000	Indirect	By trust
Common Stock	59,462	Indirect	The Mark Paul Lappe Roth IRA

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mark P. Lappe.
The shares were sold in multiple transactions at prices ranging from $25.005 to $25.07, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These securities are directly owned by the Lappe Family Trust. Mark P. Lappe is a trustee of the Lappe Family Trust and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Lappe Family Trust.
These securities are directly owned by a trust, for the benefit of the reporting person's immediate family. Mark P. Lappe, as an immediate family member of the beneficiaries of the trust, may be deemed to indirectly beneficially own the securities owned by the trust.